[CAS NO. 1883423-59-3]  MSC2530818

Ships within Stock Price Qty Total
$0.00
$0.00
Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [1883423-59-3]

Store
Catalog
SLK-S8387
Brand
Selleck
CAS
1883423-59-3

DESCRIPTION [1883423-59-3]

Overview

MDL-
Molecular Weight340.81
Molecular FormulaC18H17ClN4O
SMILESO=C(N1[C@H](C2=CC=C(Cl)C=C2)CCC1)C3=CN=C(NN=C4C)C4=C3

For research use only.

Storage

3 years,-20°C,powder
1 years,-80°C,in solvent

Shipping

Room temperature shipping(Stability testing shows this product can be shipped without any cooling measures.)

Preparing Stock Solutions

1 mg5 mg10 mg
1 mM2.9342 mL14.6709 mL29.3419 mL
5 mM0.5868 mL2.9342 mL5.8684 mL
10 mM0.2934 mL1.4671 mL2.9342 mL
50 mM0.0587 mL0.2934 mL0.5868 mL

Description

MSC2530818, a inhibitor with the of 2.6 nM, displays excellent kinase selectivity, biochemical and cellular potency, microsomal stability, and is orally bioavailable.

Targets

CDK8 [1]
(Cell-free assay)
2.6 nM

In vitro

MSC2530818 binds to CDK8 and CDK19 with similar affinity (4 nM) and shows potent inhibition of phospho-STAT1 in SW620 human colorectal carcinoma cells (IC50=8 ± 2 nM). It also demonstrates potent inhibition of WNT-dependent transcription in human cancer cell lines that have constitutively activated WNT signaling. MSC2530818 is a soluble CDK8 inhibitor with high permeability and low efflux ratio in Caco-2 cells (ER = 1.5) and does not inhibit any cytochrome P450 subtypes (Cyp IC50s > 20 μM).